Senior insider sale
Chief Financial Officer at TREVI THERAPEUTICS, INC. — senior position signals high conviction
$2.97M
352.86K shares
DELFINI LISA plans to sell 352.86K shares of TREVI THERAPEUTICS, INC. valued at approximately $2.97M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Option Exercise
Cash
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/26/2023 | Option Exercise Cash | 312.86K | — |
| Total | 312.86K | ||
Completed
Units to sell
65.07K
Market value
$571.5K
Units to sell
26.07K
Market value
$224.1K
Units to sell
4.84K
Market value
$41.1K
Units to sell
8.60K
Market value
$73.2K
Units to sell
155K
Market value
$1.26M
Units to sell
41.78K
Market value
$322.8K
Units to sell
1.50K
Market value
$12.3K
Units to sell
10K
Market value
$80.9K
Planned — Approximate Date
Units to sell
40K
Market value
$386.7K
Units
352.86K
Value
$2.97M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
9/26/2025 | 65.07K | $571.5K | — | Completed |
9/25/2025 | 26.07K | $224.1K | — | Completed |
9/24/2025 | 4.84K | $41.1K | — | Completed |
9/23/2025 | 8.60K | $73.2K | — | Completed |
9/9/2025 | 155K | $1.26M | — | Completed |
9/8/2025 | 41.78K | $322.8K | — | Completed |
8/28/2025 | 1.50K | $12.3K | — | Completed |
8/27/2025 | 10K | $80.9K | — | Completed |
| Planned — Approximate Date | ||||
10/3/2025 | 40K | $386.7K | Nasdaq | Planned |
| Total | 352.86K | $2.97M | ||